ImmunityBio, NantKwest begin patient dosing in Phase 1 clinical trial of COVID-19 vaccine candidate Read more
SPARC announces Phase 3 trial results of SDN-037 to treat inflammation and pain of ocular surgery Read more
EMA approves label update for Takeda’s HYQVIA, expands use to treat secondary immunodeficiencies Read more